CENGILD MEDICAL BERHAD
KLSE (MYR): CENGILD (0243)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.275
Today's Change
+0.005 (1.85%)
Day's Change
0.27 - 0.28
Trading Volume
47,600
Overview
Market Cap
229 Million
NOSH
834 Million
Avg Volume (4 weeks)
965,923
4 Weeks Range
0.265 - 0.30
4 Weeks Price Volatility (%)
28.57%
52 Weeks Range
0.24 - 0.345
52 Weeks Price Volatility (%)
33.33%
Previous Close
0.27
Open
0.275
Bid
0.27 x 420,500
Ask
0.275 x 72,700
Day's Range
0.27 - 0.28
Trading Volume
47,600
Financial Highlight
Latest Quarter | Ann. Date
30-Sep-2024 [#1] | 25-Nov-2024
Next QR | Est. Ann. Date
31-Dec-2024 | 27-Feb-2025
T4Q P/E | EY
19.96 | 5.01%
T4Q DY | Payout %
2.69% | 53.66%
T4Q NAPS | P/NAPS
0.13 | 2.04
T4Q NP Margin | ROE
16.06% | 10.22%
Market Buzz
2024-12-24
News and Blogs
Company Profile
Sector: HEALTH CARE
Sector: HEALTH CARE
Subsector: HEALTH CARE PROVIDERS
Subsector: HEALTH CARE PROVIDERS
Description:
Cengild Medical Berhad is a Malaysia-based investment holding company. The Company through its subsidiary, is a healthcare provider specializing in the diagnosis and treatment of gastrointestinal and liver disease. Its medical center's business activities comprise of consultant services and medical management services, which includes nursing services and clinical support services. Its medical center facilities offers 10 clinics, three endoscopy rooms, 28 beds (which include eight-day care beds), special diagnostic (treadmill stress test and echocardiography) department, two operating theatres, radiology department, accident and emergency department, pharmacy, laboratory, and central sterile supply department. In addition, it also offers 24-hour outpatient accident and emergency service, health screening, physiotherapy and histopathology services. Its imaging facilities includes fibro scan, ultrasonography, CT scan, fluoroscopy, and angiography equipment.
Discussions
1 person likes this. Showing 50 of 251 comments
The PAT quite consistent
Low gearing at 0.26
Not sure how is the Oncology JV announced in Jul23 seen not contributing to revenue.
Revenue also stagnant not much improvement.
2023-11-24 20:26
this counter are down trend. up abit then contiune drop . careful. why not move other uptrend stock ?
2023-12-06 21:27
company is doing ok but its expansion is too slow. It was listed on 2022-4-18. Its IPO proceeds should be used for expansion within 3 years. According to its latest quarterly report, its IPO money is hardly used more than one and half year later.
2023-12-07 13:10
Haha, cengild buying property instead of investing in medical business, wtf! Private placements or rights issues soon…DUMP!!!
2024-01-01 19:50
They never heard abt leasing? The same thing that they doing now so successfully. Buying a property? No need take into refurbishment and maintenance cost??? Something damn fishy…can smell from afar. The board members who agreed on this shud be sacked.
2024-01-01 20:00
Yes, it supposed to be an asset light business model. To have a hospital set-up, it is costly to operate with gestation period of 3 to 5 years upon completion. Focus should be to build its business since it is relatively new healthcare group that was established in 2017
2024-01-04 09:53
This acquisition should be scrapped. The management should re-think again of its business model. It is costly to operate a hospital without relevant expertise due to its high fixed overhead & capital expenditure & it is an impediment for its to scale up. In total RM180m needs to commit to this expansion plan
2024-01-04 15:51
the next few years (until 2027) are not going to be exciting due to growing pains. If I were you, I would sell now and buy back later
2024-01-05 10:20
SHOB
put it in my safe box see after in mid june
1 week ago
Yup...Invested...@0.32...🤓
2024-01-15 19:49
The worst performing healthcare in Bursa with almost 50% contraction. I believe many shareholders have doubt of the recent Proposed Acquisition and change of business model from asset light to heavy
2024-02-02 16:49
first time for many years, I see a healthcare counter that down so much. Typically, healthcare companies should be the most resilient counters
2024-02-02 16:52
CENGILD has been heavily mispriced. There is no reason for the overreaction in the sell-off.
The pivot from renting a building to totally owning one seems highly rationale, given there is a huge business risk if the landlord takes back the property.
As a shareholder, decision to own a building MUST be executed and thoroughly supported. Otherwise, there is a huge cloud of uncertainty with high risks of pushing the company into zero revenue if the building lease cannot be renewed.
2024-02-07 23:03
i think they should not buy a new building but instead go for a long term lease
2024-02-08 07:41
They have a bad management team that wobbling around about their business strategy. light business model is a good strategy like in the case of Qualitas and Mediviron with high EBITDA. As a small Group with track record of 2017, it is bad strategy to commit such a high capital expenditure
2024-02-08 16:45
If this Group is already been more than a decade long, then it is fine but not now. It is a high risk strategy at current juncture as they are still figuring the building blocks
2024-02-08 16:46
Mr Warchest, who says Qualitas and Mediviron have a high EBITDA. Their structure is weak, especially Mediviron, and not sustainable. Cengild GI Medical Centre is much better.
2024-02-20 10:57
The passing of Dato Dr K L GOH last year ,was a big blow to the Cengild GI Centre.
But now , they still have a very capable team of doctors there.
2024-02-20 16:41
Good or not, you can analysis both Qualitas & Mediviron business models and financials. You can buy their documents via SSM. So far Cengild is still wobbling with their financials and business model
2024-02-22 11:09
The stock regains its momentum after a short consolidation. (0.30, upon writing)
2024-02-22 15:56
Xi wants to build China industrial industry is so competitive that others simply can't compete with it. Companies still have to invest in China if they want to keep their costs down maintaining their profit margins. At the same time China dominates EV cars industry, solar industry and catching up on chip ...
China takes over the US in terms of nominal GDP is not a matter of if but when. Interesting time ahead.
2024-03-07 00:08
Ya, it is useless now , since they are on the way to change a light assets business model to a heavy assets business model...
2024-07-28 14:45
They just follow the same model as CVSKL but specialise in Gastrointestinal & Liver Disease
2024-07-31 11:07
But CVSKL still rented their space. But still they are much more profitable than Cengild. the management team of Cengild is not capable of growing the business but yet not prudent on the Capex spending
2024-07-31 11:10
Post a Comment
Featured Posts
Latest Videos
MQ Trading Signals
Time
Signal
Duration
Type
2024-12-24 16:30:00
EMA 5
10 Mins
SELL
2024-12-24 16:20:00
EMA 5
5 Mins
SELL
2024-12-24 16:15:00
ADX
5 Mins
SELL
2024-12-24 16:15:00
TURTLE SYSTEM 20
5 Mins
SELL
2024-12-24 16:15:00
TURTLE SYSTEM 55
5 Mins
SELL
Apps
Top Articles
1
Mercury Securities Research
2
Stock Market Enthusiast
3
save malaysia!
4
THE INVESTMENT APPROACH OF CALVIN TAN
5
Good Articles to Share
6
Good Articles to Share
7
Good Articles to Share
U.S. has pretty good chance to see more white Christmas: forecast
8
Good Articles to Share
U.S. California's population rebounds to near pre-pandemic level
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
cytew
Reversal of trend is intact now..
2023-11-10 07:36